Lymph node dissection for bladder cancer: The issue of extent and feasibility in the minimally invasive era

Reza Ghavamian, A. Ari Hakimi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Lymph node dissection in bladder cancer is an integral part of radical cystectomy. It allows for accurate staging of the patient and will, therefore, serve to dictate additional treatment and add prognostic information. The issue of what is an adequate lymphadenectomy as to the extent and boundaries of the operation, specifically the cephalad extent, has been the focus of recent debate. Some have suggested that lymph node yield, in terms of number, could serve as a surrogate for the adequacy of the node dissection and, thus, the oncologic efficacy of the operation. It has also been suggested that it is a marker for the experience of the operating surgeon. What is meant by a limited, standard and extended lymph node dissection varies among different publications. Recent evidence suggests that an 'extended' node dissection infers oncologic efficacy. With the advent of minimally invasive and, specifically, robotic-assisted surgery, more cystectomies are approached robotically. As such, there has been recent debate as to whether a robotic-assisted procedure can emulate the open approach, satisfying the accepted boundaries and extent of dissection and ultimately leading to equivalent oncologic outcomes without increasing morbidity. In this review, we focus on the extent of lymphadenectomy in bladder cancer by reviewing the lymphatic drainage and arguments in favor of a more extended dissection. We will then address the minimally invasive techniques, focusing on robotic-assisted surgery, and review the evidence suggesting that this is a promising new technique that results in acceptable nodal yield and potentially equivalent oncologic outcomes with no added morbidity.

Original languageEnglish (US)
Pages (from-to)1783-1792
Number of pages10
JournalExpert Review of Anticancer Therapy
Volume9
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Lymph Node Excision
Urinary Bladder Neoplasms
Dissection
Robotics
Cystectomy
Morbidity
Publications
Drainage
Lymph Nodes
Therapeutics

Keywords

  • Bladder cancer
  • Lymphadenectomy
  • Radical cystectomy
  • Robotic cystectomy
  • Robotics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Lymph node dissection for bladder cancer : The issue of extent and feasibility in the minimally invasive era. / Ghavamian, Reza; Hakimi, A. Ari.

In: Expert Review of Anticancer Therapy, Vol. 9, No. 12, 12.2009, p. 1783-1792.

Research output: Contribution to journalArticle

@article{3269849cc6854d248d76e94f2302283b,
title = "Lymph node dissection for bladder cancer: The issue of extent and feasibility in the minimally invasive era",
abstract = "Lymph node dissection in bladder cancer is an integral part of radical cystectomy. It allows for accurate staging of the patient and will, therefore, serve to dictate additional treatment and add prognostic information. The issue of what is an adequate lymphadenectomy as to the extent and boundaries of the operation, specifically the cephalad extent, has been the focus of recent debate. Some have suggested that lymph node yield, in terms of number, could serve as a surrogate for the adequacy of the node dissection and, thus, the oncologic efficacy of the operation. It has also been suggested that it is a marker for the experience of the operating surgeon. What is meant by a limited, standard and extended lymph node dissection varies among different publications. Recent evidence suggests that an 'extended' node dissection infers oncologic efficacy. With the advent of minimally invasive and, specifically, robotic-assisted surgery, more cystectomies are approached robotically. As such, there has been recent debate as to whether a robotic-assisted procedure can emulate the open approach, satisfying the accepted boundaries and extent of dissection and ultimately leading to equivalent oncologic outcomes without increasing morbidity. In this review, we focus on the extent of lymphadenectomy in bladder cancer by reviewing the lymphatic drainage and arguments in favor of a more extended dissection. We will then address the minimally invasive techniques, focusing on robotic-assisted surgery, and review the evidence suggesting that this is a promising new technique that results in acceptable nodal yield and potentially equivalent oncologic outcomes with no added morbidity.",
keywords = "Bladder cancer, Lymphadenectomy, Radical cystectomy, Robotic cystectomy, Robotics",
author = "Reza Ghavamian and Hakimi, {A. Ari}",
year = "2009",
month = "12",
doi = "10.1586/ERA.09.147",
language = "English (US)",
volume = "9",
pages = "1783--1792",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "12",

}

TY - JOUR

T1 - Lymph node dissection for bladder cancer

T2 - The issue of extent and feasibility in the minimally invasive era

AU - Ghavamian, Reza

AU - Hakimi, A. Ari

PY - 2009/12

Y1 - 2009/12

N2 - Lymph node dissection in bladder cancer is an integral part of radical cystectomy. It allows for accurate staging of the patient and will, therefore, serve to dictate additional treatment and add prognostic information. The issue of what is an adequate lymphadenectomy as to the extent and boundaries of the operation, specifically the cephalad extent, has been the focus of recent debate. Some have suggested that lymph node yield, in terms of number, could serve as a surrogate for the adequacy of the node dissection and, thus, the oncologic efficacy of the operation. It has also been suggested that it is a marker for the experience of the operating surgeon. What is meant by a limited, standard and extended lymph node dissection varies among different publications. Recent evidence suggests that an 'extended' node dissection infers oncologic efficacy. With the advent of minimally invasive and, specifically, robotic-assisted surgery, more cystectomies are approached robotically. As such, there has been recent debate as to whether a robotic-assisted procedure can emulate the open approach, satisfying the accepted boundaries and extent of dissection and ultimately leading to equivalent oncologic outcomes without increasing morbidity. In this review, we focus on the extent of lymphadenectomy in bladder cancer by reviewing the lymphatic drainage and arguments in favor of a more extended dissection. We will then address the minimally invasive techniques, focusing on robotic-assisted surgery, and review the evidence suggesting that this is a promising new technique that results in acceptable nodal yield and potentially equivalent oncologic outcomes with no added morbidity.

AB - Lymph node dissection in bladder cancer is an integral part of radical cystectomy. It allows for accurate staging of the patient and will, therefore, serve to dictate additional treatment and add prognostic information. The issue of what is an adequate lymphadenectomy as to the extent and boundaries of the operation, specifically the cephalad extent, has been the focus of recent debate. Some have suggested that lymph node yield, in terms of number, could serve as a surrogate for the adequacy of the node dissection and, thus, the oncologic efficacy of the operation. It has also been suggested that it is a marker for the experience of the operating surgeon. What is meant by a limited, standard and extended lymph node dissection varies among different publications. Recent evidence suggests that an 'extended' node dissection infers oncologic efficacy. With the advent of minimally invasive and, specifically, robotic-assisted surgery, more cystectomies are approached robotically. As such, there has been recent debate as to whether a robotic-assisted procedure can emulate the open approach, satisfying the accepted boundaries and extent of dissection and ultimately leading to equivalent oncologic outcomes without increasing morbidity. In this review, we focus on the extent of lymphadenectomy in bladder cancer by reviewing the lymphatic drainage and arguments in favor of a more extended dissection. We will then address the minimally invasive techniques, focusing on robotic-assisted surgery, and review the evidence suggesting that this is a promising new technique that results in acceptable nodal yield and potentially equivalent oncologic outcomes with no added morbidity.

KW - Bladder cancer

KW - Lymphadenectomy

KW - Radical cystectomy

KW - Robotic cystectomy

KW - Robotics

UR - http://www.scopus.com/inward/record.url?scp=73349139510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73349139510&partnerID=8YFLogxK

U2 - 10.1586/ERA.09.147

DO - 10.1586/ERA.09.147

M3 - Article

C2 - 19954290

AN - SCOPUS:73349139510

VL - 9

SP - 1783

EP - 1792

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 12

ER -